Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2024-02, Vol.109 (2), p.671-675
Hauptverfasser:	Murphy, Tracy, Zou, Jinfeng, Arruda, Andrea, Wang, Ting Ting, Zhao, Zhen, Zheng, Yangqiao, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Minden, Mark D, Schimmer, Aaron, Sibai, Hassan, Yee, Karen, Capo-Chichi, Jose-Mario, Stockley, Tracy, Schuh, Andre, Bratman, Scott V, Chan, Steven M
Format:	Artikel
Sprache:	eng
Schlagworte:	Humans Isocitrate Dehydrogenase - genetics Letter to the Editor Leukemia, Myeloid, Acute - diagnosis Leukemia, Myeloid, Acute - genetics Mutation Neoplasm, Residual - diagnosis Neoplasm, Residual - genetics Prognosis RNA Splicing Factors - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!